In addition, the Drp-1 inhibitor administrated before the onset of cerebral ischemia may have beneficial effects in the case of cerebrovascular diseases, including carotid occlusive disease, and moyamoya disease to prevent cerebral ischemia in the future. The gene discussed is DNM1L; the disease is cerebrovascular disorder.